Cargando…
Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103874/ https://www.ncbi.nlm.nih.gov/pubmed/30134893 http://dx.doi.org/10.1186/s12933-018-0760-6 |
| _version_ | 1783349387413422080 |
|---|---|
| author | Shehadeh, Naim Raz, Itamar Nakhleh, Afif |
| author_facet | Shehadeh, Naim Raz, Itamar Nakhleh, Afif |
| author_sort | Shehadeh, Naim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6103874 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61038742018-08-30 Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease Shehadeh, Naim Raz, Itamar Nakhleh, Afif Cardiovasc Diabetol Commentary BioMed Central 2018-08-22 /pmc/articles/PMC6103874/ /pubmed/30134893 http://dx.doi.org/10.1186/s12933-018-0760-6 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Commentary Shehadeh, Naim Raz, Itamar Nakhleh, Afif Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease |
| title | Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease |
| title_full | Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease |
| title_fullStr | Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease |
| title_full_unstemmed | Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease |
| title_short | Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease |
| title_sort | cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103874/ https://www.ncbi.nlm.nih.gov/pubmed/30134893 http://dx.doi.org/10.1186/s12933-018-0760-6 |
| work_keys_str_mv | AT shehadehnaim cardiovascularbenefitinthelimelightshiftingtype2diabetestreatmentparadigmtowardsearlycombinationtherapyinpatientswithovertcardiovasculardisease AT razitamar cardiovascularbenefitinthelimelightshiftingtype2diabetestreatmentparadigmtowardsearlycombinationtherapyinpatientswithovertcardiovasculardisease AT nakhlehafif cardiovascularbenefitinthelimelightshiftingtype2diabetestreatmentparadigmtowardsearlycombinationtherapyinpatientswithovertcardiovasculardisease |